Taghormonal contraception

New study on use of combined and progestogen-only hormonal contraception and breast cancer risk

N

Faculty of Sexual and Reproductive Healthcare, Royal College of the Obstetricians and Gynaecologists (UK), 22 March 2023 FSRH response to new study on use of combined and progestogen-only hormonal contraception and breast cancer risk: A new observational study by Fitzpatrick, et al., published in PLOS Medicine investigated the association between current or recent use of combined oral and...

ASPOG 2023: Exploring the Tapestry of Psychosocial Obstetrics & Gynaecology

A

Australian Society for Psychosocial Obstetrics & Gynaecology (ASPOG), 2023 ASPOG 2023: Exploring the Tapestry of Psychosocial Obstetrics & Gynaecology is the 47th Annual Scientific Meeting of the Australian Society for Psychosocial Obstetrics & Gynaecology (ASPOG), to be held from 24-26 February 2023 at the Hotel Grand Chancellor, Adelaide.   It is a chance to hear from many different...

Changes in use of hormonal long‐acting reversible contraceptive methods in Australia 2006 – 2018

C

Changes in use of hormonal long‐acting reversible contraceptive methods in Australia between 2006 and 2018: A population‐based study Luke E. Grzeskowiak,  Helen Calabretto, Natalie Amos, Danielle Mazza, Jenni Ilomaki ANZJOG First published: 23 October 2020,  Abstract: Background Long‐acting reversible contraceptives (LARCs) are promoted internationally as a key strategy for reducing unintended...

Shortage of norethisterone-containing pills in Australia: Advice for GPs

S

July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...

Updated IMPLANON NXT Procedures Statement

U

SHINE SA, September 2020 The contraceptive implant (Implanon NXT) is one of the most effective contraceptives available. Along with the hormonal and copper IUDs, it is classified as Long Acting Reversible Contraception (LARC) which are recommended as first-line options for all people choosing to use contraception. SHINE SA wish to alert clinicians to important updated information about Implanon...

RACGP offers new suite of IUD resources

R

RACGP, 25th August 2020 The newly released suite consists of five intrauterine device (IUD) resources, including a checklist and patient confirmation form, patient pre- and post-insertion checklist, practitioner checklist and disclaimer. Current evidence-based options for pain relief during IUD procedures are provided as an appendix. Dr Amy Moten, Chair of the RACGP Specific Interests Sexual...

Your sidebar area is currently empty. Hurry up and add some widgets.